ArticleOncology and therapy2021

Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut Microbiota.

Daqiang He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.